About Us
Heat Biologics (“Heat”) is a clinical-stage company focused on developing its novel “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) off-the-shelf therapeutic vaccines to combat a wide range of cancers and other diseases. Heat’s ImPACT therapy effectively transforms living tumor cells into powerful machines that “pump out” important antigens to robustly stimulate the immune system against the targeted disease.
|
|
 |
ImPACT Technology
Heat Biologics' ImPACT Therapy is a novel off-the-shelf therapeutic vaccine platform that enables the immune system to activate a powerful immune response against a wide range of cancers and other diseases. We are currently in Phase II clinical trials with our first ImPACT drug against non-small cell lung cancer and will be entering clinical trials with new ImPACT drugs against additional indications in 2012.
 |
|
|
|
